| Original language | English |
|---|---|
| Pages (from-to) | 3534-3537 |
| Number of pages | 4 |
| Journal | Allergy: European Journal of Allergy and Clinical Immunology |
| Volume | 76 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - Nov 2021 |
| Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Immunology and Allergy
- Immunology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, No. 11, 11.2021, p. 3534-3537.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - TH2 cytokines and Staphylococcus aureus cooperatively induce atopic dermatitis-like transcriptomes
AU - Murai-Yamamura, Mika
AU - Garcet, Sandra
AU - Yamamura, Kazuhiko
AU - Gonzalez, Juana
AU - Miura, Shunsuke
AU - Li, Xuan
AU - Hur, Hong
AU - Guttman-Yassky, Emma
AU - Krueger, James G.
N1 - Funding Information: KY was supported by Japan Society for the Promotion of Science (JSPS) overseas research fellowships from 2020 to 2022. SM was supported by a fellowship from the Uehara Memorial Foundation (award number: 201830050). EGY has received research funds (grants paid to the institution) from Abbvie, Almirall, Amgen, AnaptysBio, Asana Biosciences, AstraZeneca, Boerhinger‐Ingelhiem, Celgene, Dermavant, DS Biopharma, Eli Lilly, Galderma, Glenmark/Ichnos Sciences, Innovaderm, Janssen, Kiniksa, Kyowa Kirin, Leo Pharma, Novan, Novartis, Pfizer, Ralexar, Regeneron Pharmaceuticals, Inc., Sienna Biopharma, UCB, and Union Therapeutics/Antibiotx; and is a consultant for Abbvie, Aditum Bio, Almirall, Alpine, Amgen, Arena, Asana Biosciences, AstraZeneca, Bluefin Biomedicine, Boerhinger‐Ingelhiem, Boston Pharmaceuticals, Botanix, Bristol‐Meyers Squibb, Cara Therapeutics, Celgene, Clinical Outcome Solutions, DBV, Dermavant, Dermira, Douglas Pharmaceutical, DS Biopharma, Eli Lilly, EMD Serono, Evelo Bioscience, Evidera, FIDE, Galderma, GSK, Haus Bioceuticals, Ichnos Sciences, Incyte, Kyowa Kirin, Larrk Bio, Leo Pharma, Medicxi, Medscape, Neuralstem, Noble Insights, Novan, Novartis, Okava Pharmaceuticals, Pandion Therapeutics, Pfizer, Principia Biopharma, RAPT Therapeutics, Realm, Regeneron Pharmaceuticals, Inc., Sanofi, SATO Pharmaceutical, Sienna Biopharma, Seanegy Dermatology, Seelos Therapeutics, Serpin Pharma, Siolta Therapeutics, Sonoma Biotherapeutics, Sun Pharma, Target PharmaSolutions, Union Therapeutics, Vanda Pharmaceuticals, Ventyx Biosciences, Vimalan, and Concert. JGK has received research funds (grants paid to institution) from Novartis, Pfizer, Amgen, Lilly, Boehringer, Innovaderm, BMS, Janssen, Abbvie, Paraxel, Leo Pharma, Vitae, Akros, Regeneron, Allergan, Novan, Biogen MA, Sienna, UCB, Celgene, Botanix, Incyte, Avillion, and Exicure, and personal fees from Novartis, Pfizer, Amgen, Lilly, Boehringer, BiogenIdec, Abbvie, Leo Pharma, Escalier, Valeant, Aurigne, Allergan, Asana, UCB, Sienna, Celgene, Nimbus, Menlo, Aristea, Sanofi, Sun Pharma, Almirall, Arena, BMS, Ventyx, Aclaris, and Galapagos.
PY - 2021/11
Y1 - 2021/11
UR - http://www.scopus.com/inward/record.url?scp=85113148878&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85113148878&partnerID=8YFLogxK
U2 - 10.1111/all.15035
DO - 10.1111/all.15035
M3 - Letter
C2 - 34358351
AN - SCOPUS:85113148878
SN - 0105-4538
VL - 76
SP - 3534
EP - 3537
JO - Allergy: European Journal of Allergy and Clinical Immunology
JF - Allergy: European Journal of Allergy and Clinical Immunology
IS - 11
ER -